An ISV gears up for another year of double-digit growth by developing a strong focus and expertise in FDA-regulated industries.
A large percentage of you may not identify personally with the niche markets that ISV Innovatum sells to, which include food and life sciences. However, the ways Innovatum differentiates itself from much larger competitors can easily be applied to any other industry and especially any other highly regulated industry. It’s important to note, too, that not only is Innovatum realizing year-over-year doubledigit growth, it’s doing so without any VC funding, and it’s debt-free.
Before you can appreciate how Innovatum differentiates itself, it’s important to understand what it does. This ISV makes enterprise software systems for managing content that’s used to generate labels in FDA-regulated industries. Innovatum President and CEO Ardi Batmanghelidj shares an example of an orthopedic surgeon in an operating room performing a hip replacement. “The surgeon relies on the information contained on the label that’s on the box to determine which part to use,” he says. “That label is managed and printed by our software.”